Literature DB >> 14081667

MECHANISM OF ATRIAL FLUTTER AND FIBRILLATION INDUCED BY ACONITINE IN THE DOG, WITH OBSERVATIONS ON THE ROLE OF CHOLINEGIC FACTORS.

P L SHARMA.   

Abstract

The topical application of aconitine nitrate to the right atrial appendage in the "intact" anaesthetized dog produced atrial flutter. Premature systoles with fixed coupling preceded the development of flutter. In early stages of the arrhythmia, atrial rate was irregularly irregular. Also, the form of flutter beats was similar to that of preceding premature systoles. The fibrillatory activity of acetylcholine described by earlier workers has been confirmed. Transient atrial dissociation was seen after intravenous injection or topical application of acetylcholine. The occurrence of fibrillation in the left atrium after focal application of acetylcholine has been demonstrated, while the right atrial appendage containing the ectopic focus induced by aconitine continued to flutter. Aconitine produced slow-rate flutter in dogs treated with atropine or hemicholinium; this flutter was easily distinguishable from the sinus tachycardia produced by these drugs, by recording the electrocardiogram from a direct atrial lead from the area treated with aconitine, but not from limb lead II. The importance of these findings in the interpretation of the mechanism of atrial flutter and fibrillation is discussed.

Entities:  

Keywords:  ACETYLCHOLINE; ACONITE; ATROPINE; AURICULAR FIBRILLATION; AURICULAR FLUTTER; DOGS; ELECTRIC STIMULATION; EXPERIMENTAL LAB STUDY; PHARMACOLOGY; TOXICOLOGIC REPORT; VAGUS NERVE

Mesh:

Substances:

Year:  1963        PMID: 14081667      PMCID: PMC1703834          DOI: 10.1111/j.1476-5381.1963.tb01535.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  17 in total

1.  Mechanism of origin of ectopic beats: a hypothesis, with special reference to extrasystoles.

Authors:  D SCHERF; A SCHOTT
Journal:  Am J Cardiol       Date:  1959-03       Impact factor: 2.778

2.  Mechanism of experimental atrial flutter.

Authors:  A LANARI; A LAMBERTINI; A RAVIN
Journal:  Circ Res       Date:  1956-05       Impact factor: 17.367

3.  Acetylcholine and cardiac fibrillation.

Authors:  J H BURN
Journal:  Br Med Bull       Date:  1957-09       Impact factor: 4.291

4.  The formation of acetylcholine in the heart; its effect on the systemic output and its importance for auricular fibrillation caused by aconitine.

Authors:  J H BURN; E M VAUGHAN WILLIAMS; J M WALKER
Journal:  J Physiol       Date:  1956-02-28       Impact factor: 5.182

5.  Latency of isolated cat atrium and its possible relationship to fibrillation.

Authors:  J R Dipalma
Journal:  Am J Physiol       Date:  1955-01

6.  Experimental studies on arrhythmias caused by focal cooling of the heart.

Authors:  D SCHERF; S BLUMENFELD; M GOLBEY; C LADOPOULOS; F ROTH
Journal:  Am Heart J       Date:  1955-02       Impact factor: 4.749

7.  Aconitine-induced auricular arrhythmias and their relation to circus-movement flutter.

Authors:  B B BROWN; G H ACHESON
Journal:  Circulation       Date:  1952-10       Impact factor: 29.690

8.  Action of aconitine on the cold-blooded heart.

Authors:  A M WEDD; S M TENNEY
Journal:  Proc Soc Exp Biol Med       Date:  1953-10

9.  Experimental cardia arrhythmias and quinidine-like drugs.

Authors:  G S DAWES
Journal:  Pharmacol Rev       Date:  1952-03       Impact factor: 25.468

10.  Antifibrillatory drugs.

Authors:  J R DIPALMA; J E SCHULTZ
Journal:  Medicine (Baltimore)       Date:  1950-05       Impact factor: 1.889

View more
  3 in total

Review 1.  Déjà vu in the theories of atrial fibrillation dynamics.

Authors:  José Jalife
Journal:  Cardiovasc Res       Date:  2010-11-19       Impact factor: 10.787

Review 2.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  Atrial Fibrillation (Part 1): Pathophysiology, Risk Factors, and Therapeutic Basis.

Authors:  Fatima Dumas Cintra; Marcio Jansen de Oliveira Figueiredo
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.